Lakeshore Biopharma Co. Ltd.Preferred / convertible
13F holders, Q2 2025 (June 30)19holders +1
1new positions
0sold out
1famous investor
$0.06avg. 13F price*
At the end of Q2 2025, 19 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Athos Capital Ltd ($132K), LMR Partners LLP ($42K) and Toronto Dominion Bank ($42K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $42K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 1,048,420 shares bought and 1,970 shares sold, net +1,046,450 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Athos Capital Ltd | — | No change | 128,981 | $132K |
| LMR Partners LLP | — | No change | 1,052,461 | $42K |
| Toronto Dominion Bank | — | New | 1,048,320 | $42K |
| Valliance Asset Management Ltd | — | No change | 750,000 | $30K |
| Jane Street Group, LLC | — | No change | 498,301 | $20K |
| Finepoint Capital LP | — | No change | 489,999 | $20K |
| Bracebridge Capital, LLC | — | No change | 232,323 | $9K |
| Calamos Advisors LLC | — | No change | 146,040 | $5K |
| Q Global Advisors, LLC | — | No change | 130,600 | $5K |
| Whitebox Advisors LLC | — | No change | 125,000 | $5K |
| Two Sigma Securities, LLC | — | Reduce -1.8% | 105,036 | $4K |
| D. E. Shaw & Co. | — | No change | 100,000 | $4K |
| Walleye Capital LLC | — | No change | 95,030 | $4K |
| Saba Capital Management, L.P. | — | No change | 97,299 | $4K |
| Cantor Fitzgerald, L. P. | — | No change | 76,931 | $3K |
| Clear Street LLC | — | Add +0.2% | 47,724 | $2K |
| Ancora Advisors LLC | — | No change | 5,050 | $201 |
| HGC Investment Management Inc. | — | No change | 5,000 | $200 |
| SkyView Investment Advisors, LLC | — | No change | 12,210 | $0 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.